1. Home
  2. SURG vs UBX Comparison

SURG vs UBX Comparison

Compare SURG & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SURG
  • UBX
  • Stock Information
  • Founded
  • SURG 2006
  • UBX 2009
  • Country
  • SURG United States
  • UBX United States
  • Employees
  • SURG N/A
  • UBX N/A
  • Industry
  • SURG Advertising
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SURG Consumer Discretionary
  • UBX Health Care
  • Exchange
  • SURG Nasdaq
  • UBX Nasdaq
  • Market Cap
  • SURG 31.3M
  • UBX 38.6M
  • IPO Year
  • SURG N/A
  • UBX 2018
  • Fundamental
  • Price
  • SURG $1.47
  • UBX $2.07
  • Analyst Decision
  • SURG Buy
  • UBX Strong Buy
  • Analyst Count
  • SURG 2
  • UBX 2
  • Target Price
  • SURG $8.50
  • UBX $7.00
  • AVG Volume (30 Days)
  • SURG 129.0K
  • UBX 339.4K
  • Earning Date
  • SURG 03-11-2025
  • UBX 11-04-2024
  • Dividend Yield
  • SURG N/A
  • UBX N/A
  • EPS Growth
  • SURG N/A
  • UBX N/A
  • EPS
  • SURG N/A
  • UBX N/A
  • Revenue
  • SURG $83,602,653.00
  • UBX N/A
  • Revenue This Year
  • SURG N/A
  • UBX N/A
  • Revenue Next Year
  • SURG $59.69
  • UBX $33.62
  • P/E Ratio
  • SURG N/A
  • UBX N/A
  • Revenue Growth
  • SURG N/A
  • UBX N/A
  • 52 Week Low
  • SURG $1.33
  • UBX $0.94
  • 52 Week High
  • SURG $9.23
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • SURG 31.02
  • UBX 62.50
  • Support Level
  • SURG $1.33
  • UBX $2.05
  • Resistance Level
  • SURG $1.45
  • UBX $2.42
  • Average True Range (ATR)
  • SURG 0.08
  • UBX 0.31
  • MACD
  • SURG -0.01
  • UBX -0.01
  • Stochastic Oscillator
  • SURG 16.67
  • UBX 41.67

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: